文献速递肺栓塞与肺血管病

超声心动图参数在肺动脉高压中的风险预测:PVDOMICS网络 insights

Echocardiographic Parameters and Risk Prediction in Pulmonary Arterial Hypertension: Insights From the Redefining Pulmonary Hypertension Through Pulmonary Vascular Disease Phenomics Network.
PubMed 文献 · Chest · 2025-04-12

该研究基于PVDOMICS项目405例(现患336例,新发69例)肺动脉高压患者,评估右心室超声心动图功能分级与功能结局的关联,并探讨其在传统风险评分之外的预后价值。结果显示右心室功能减退与NT-proBNP升高、6分钟步行距离降低及COMPERA和REVEAL Lite 2.0风险评分升高相关,且超声变量加入风险模型使C统计量提高10%,严重右心室功能障碍组全因死亡率最高增加三倍。

要点

  • 右心室超声功能减退与PAH患者运动耐量下降和风险评分升高独立相关。
  • 超声参数加入COMPERA和REVEAL Lite 2.0模型使C统计量提高10%。
  • 严重右心室功能障碍与全因死亡率增加相关,最高达三倍。

核心结论

  • 超声心动图评估的右心室功能减退与新发和现患PAH患者的不良结局相关,并为现有PH风险预测评分和侵入性血流动力学提供额外价值。

研究设计与样本

  • 在PVDOMICS项目中纳入405例PAH参与者(现患n=336,新发n=69),采用多变量线性回归、惩罚Cox回归和聚类分析结合生存分析。

主要发现

  • 右心室功能减退与NT-proBNP升高、6分钟步行距离降低及COMPERA和REVEAL Lite 2.0风险评分升高相关(校正PAH病程和混杂因素后)。
  • 超声变量加入COMPERA和REVEAL 2.0评分模型使C统计量提高10%。
  • 严重右心室功能障碍组与全因死亡率增加相关,多变量模型校正混杂因素、PAH病程和侵入性肺血管阻力后死亡率最高增加三倍。

临床怎么用

  • 可将右心室超声功能评估纳入PAH风险分层,补充传统风险评分和侵入性血流动力学信息。
  • 通过聚类分析定义的右心室功能严重程度可能有助于预后判断和监测治疗反应。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Echocardiographic metrics of right ventricular (RV) chamber size and function enhance prognostication, risk stratification, and measurement of therapeutic response in patients with pulmonary arterial hypertension (PAH), though the most effective metrics remain unclear. RESEARCH QUESTION: In a well-phenotyped cohort of patients with incident and prevalent PAH, can qualitative grades of RV echocardiographic function be established based on their association with functional outcomes, and do they demonstrate prognostic value beyond traditional risk scores? STUDY DESIGN AND METHODS: In the Redefining Pulmonary Hypertension Through Pulmonary Vascular Disease Phenomics (PVDOMICS) program, 405 (prevalent, n = 336; incident, n = 69) participants were investigated. Multivariable linear regression examined associations with 6-minute walk distance and the Comparative Prospective Registry for Newly Initiated Therapies (COMPERA) and the Registry to Evaluate Early and Long-Term PAH Disease Management (REVEAL) Lite 2.0 PAH risk scores. Penalized Cox regression was used to develop new models combining prior risk score variables with echo parameters. Cluster analysis combined with survival analysis adjusting for potential confounders was used to demonstrate prognostic significance. RESULTS: In both incident and prevalent PAH, reduced RV function was associated with increased N-terminal pro-B-type natriuretic peptide levels, reduced 6-minute walk distance, and increased COMPERA and REVEAL Lite 2.0 risk scores after adjusting for duration of PAH and relevant confounders. The addition of echocardiographic variables to models incorporating the COMPERA and REVEAL 2.0 scores yielded a 10% increase in the C-statistic. The severe RV dysfunction group was associated with increased all-cause mortality, with up to a threefold increase in mortality in multivariable models adjusted for relevant confounders, PAH duration, and invasive pulmonary vascular resistance. INTERPRETATION: Our results show that reduced RV function on echocardiography in PAH is associated with worsened outcomes in incident and prevalent PAH. Echocardiographic assessment of RV function provided additional value to existing PH risk prediction scores and invasive hemodynamics. Furthermore, defining severity of RV function through cluster analysis has important implications for risk prognostication, with potential application to monitor response to therapy.

来源:Chest,查看原文。版权归原作者所有。

引用

  1. Mukherjee M, Jani VP, Osgueritchian R, et al. Echocardiographic Parameters and Risk Prediction in Pulmonary Arterial Hypertension: Insights From the Redefining Pulmonary Hypertension Through Pulmonary Vascular Disease Phenomics Network. Chest. 2025. PMID: 40222714. doi:10.1016/j.chest.2025.04.007

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。